semaglutide and sjogren's in Cardiometabolic Diseases: SELECTing the Target Population GLP-1 Medications and Dry Mouth:

Signalling from the periphery to the brain that regulates energy homeostasis

Ozempic (semaglutide) is a brand-name injectable medication that is approved by the Food and Drug Administration (FDA) for the treatment of Type 2 diabetes and to reduce the risk of major cardiovascular events (such as heart attack, stroke, or death) in adults with Type 2 diabetes and known cardiovascular disease

Part of why addiction has been so difficult to treat is that humans are complex entities

otherwise, follow standard monitoring per diabetes and CKD care guidelines

Like diabetes and high blood pressure, for example, which have always been treated with a combination approach.